title: Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia.
authors.forename: M G
authors.initials: MG
authors.lastname: Castiglioni
authors.forename: P
authors.initials: P
authors.lastname: Scatena
authors.forename: C
authors.initials: C
authors.lastname: Pandolfo
authors.forename: S
authors.initials: S
authors.lastname: Mechelli
authors.forename: M
authors.initials: M
authors.lastname: Bianchi
mesh_terms: D000368:Aged; D000741:Anemia, Aplastic / Q000139:chemically induced / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D000069283:Rituximab; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine